SARS-CoV-2 Reinfections: Overview of Efficacy and Duration of Natural and Hybrid Immunity

Stefan Pilz; Verena Theiler‐Schwetz; Christian Trummer; Robert Krause; John P A Ioannidis

doi:10.2139/ssrn.4005459

Related publications

Article2022

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity

Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, Robert Krause, John P A Ioannidis

Article2023

Association Between Duration of SARS-CoV-2 Positivity and Long COVID

Chiara Pozzi, Riccardo Sarti, Riccardo Levi, Maximiliano Mollura, Elena Azzolini, Riccardo Barbieri, Alberto Mantovani, María Rescigno

Editorial Material2022

Does natural and hybrid immunity obviate the need for frequent vaccine boosters against <scp>SARS‐CoV</scp>‐2 in the endemic phase?

Stefan Pilz, John P A Ioannidis

Preprint2022

Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: a population-level study

Snežana Medić, Cleo Anastassopoulou, Zagorka Lozanov-Crvenković, Vladimir Vuković, Nataša Dragnić, Vladimir Petrović, Mioljub Ristić, Tatjana Pustahija, Zoran Gojković, Athanassios Tsakris, John P A Ioannidis

Preprint2021

SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8

Valentina Salvi, Hoang Oanh Nguyen, Francesca Sozio, Tiziana Schioppa, Mattia Laffranchi, Patrizia Scapini, Mauro Passari, Ilaria Barbazza, Laura Tiberio, Nicola Tamassia, Cecília Garlanda, Annalisa Del Prete, Marco A. Cassatella, Alberto Mantovani, Silvano Sozzani, Daniela Bosisio